NLRP3 and metabolic dysfunction-associated steatohepatitis: As a result of NLRP3 inflammasome activation, TXNIP upregulation caused hepatocellular secretion of IL-1β and IL-18, thereby initiating a hepatocyte-driven sterile immune response on fructose exposure and possibly driving NASH progression (37).